| Both sides previous revisionPrevious revisionNext revision | Previous revision |
| cardio:beta_blockers:start [2026/02/12 23:43] – [Beta-Blocker Comparison Table] andrew2393cns | cardio:beta_blockers:start [2026/02/12 23:47] (current) – [Mechanism of Action] andrew2393cns |
|---|
| • Some provide additional vasodilation (α1 or NO-mediated) | • Some provide additional vasodilation (α1 or NO-mediated) |
| |
| Reference: [[autonomics:start]] | Reference: [[autonomics:start|Autonomic Receptors]] |
| |
| -------------------------------------------------------------------- | -------------------------------------------------------------------- |
| |
| ^ Drug ^ Generation ^ Beta-1 Selective ^ Alpha-1 / Vasodilation ^ Lipophilic vs Hydrophilic ^ HFrEF Mortality Benefit ^ Common Uses ^ | ^ Drug ^ Generation ^ Beta-1 Selective ^ Alpha-1 / Vasodilation ^ Lipophilic vs Hydrophilic ^ HFrEF Mortality Benefit ^ Common Uses ^ |
| | ★ [[cardio:beta_blockers:propranolol|Propranolol]] | 1st | No | No | Lipophilic | No | Migraine, tremor, portal HTN | | |[[cardio:beta_blockers:propranolol|Propranolol]] | 1st | No | No | Lipophilic | No | Migraine, tremor, portal HTN | |
| | [[cardio:beta_blockers:sotalol|Sotalol]] | 1st | No | No | Hydrophilic | No | AF, ventricular arrhythmias | | | [[cardio:beta_blockers:sotalol|Sotalol]] | 1st | No | No | Hydrophilic | No | AF, ventricular arrhythmias | |
| | ★ [[cardio:beta_blockers:metoprolol|Metoprolol]] | 2nd | Yes | No | Lipophilic | Only Succinate | HTN, CAD, AF | | |[[cardio:beta_blockers:metoprolol|Metoprolol]] | 2nd | Yes | No | Lipophilic | Only Succinate | HTN, CAD, AF | |
| | ★ [[cardio:beta_blockers:bisoprolol|Bisoprolol]] | 2nd | Yes | No | Moderate | Yes | HFrEF, HTN | | |[[cardio:beta_blockers:bisoprolol|Bisoprolol]] | 2nd | Yes | No | Moderate | Yes | HFrEF, HTN | |
| | ★ [[cardio:beta_blockers:atenolol|Atenolol]] | 2nd | Yes | No | Hydrophilic | No | HTN (historical) | | |[[cardio:beta_blockers:atenolol|Atenolol]] | 2nd | Yes | No | Hydrophilic | No | HTN (historical) | |
| | ★ [[cardio:beta_blockers:esmolol|Esmolol]] | 2nd | Yes | No | Hydrophilic | No | ICU rate control | | |[[cardio:beta_blockers:esmolol|Esmolol]] | 2nd | Yes | No | Hydrophilic | No | ICU rate control | |
| | ★ [[cardio:beta_blockers:carvedilol|Carvedilol]] | 3rd | No | Yes (alpha-1) | Lipophilic | Yes | HFrEF, HTN | | |[[cardio:beta_blockers:carvedilol|Carvedilol]] | 3rd | No | Yes (alpha-1) | Lipophilic | Yes | HFrEF, HTN | |
| | ★ [[cardio:beta_blockers:labetalol|Labetalol]] | 3rd | No | Yes (alpha-1) | Moderate | No | HTN emergency, pregnancy | | |[[cardio:beta_blockers:labetalol|Labetalol]] | 3rd | No | Yes (alpha-1) | Moderate | No | HTN emergency, pregnancy | |
| | ★ [[cardio:beta_blockers:nebivolol|Nebivolol]] | 3rd | Yes | NO-mediated | Lipophilic | No | HTN | | |[[cardio:beta_blockers:nebivolol|Nebivolol]] | 3rd | Yes | Nitric Oxide-Mediated | Lipophilic | No | HTN | |
| ===== Intrinsic Sympathomimetic Activity (ISA) ===== | ===== Intrinsic Sympathomimetic Activity (ISA) ===== |
| |
